July 29th, 2022
•This work analyzes the vector dose and exposure time required to induce neuroinflammation, neurodegeneration, and motor impairment in this preclinical model of Parkinson's disease. These vectors encoding the human α-synuclein are delivered into the substantia nigra to recapitulate the synuclein pathology associated with Parkinson's disease.
Tags
Related Videos
Intracranial Injection of Adeno-associated Viral Vectors
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Methods to Characterize Spontaneous and Startle-induced Locomotion in a Rotenone-induced Parkinson's Disease Model of Drosophila
Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors
Convection Enhanced Delivery of Optogenetic Adeno-associated Viral Vector to the Cortex of Rhesus Macaque Under Guidance of Online MRI Images
In Vivo Direct Reprogramming of Resident Glial Cells into Interneurons by Intracerebral Injection of Viral Vectors
Cochlear Surface Preparation in the Adult Mouse
Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
The 6-hydroxydopamine Rat Model of Parkinson's Disease
Copyright © 2024 MyJoVE Corporation. 판권 소유